Author

Stephanie L. Muller

Consejo Nacional de Investigaciones Científicas y Técnicas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Assay:imaging· 1 Approach:statistical model· 1

Frequent Co-Authors

Carla PallaviciniiD· 2 shared Enzo TagliazucchiiD· 2 shared Federico CavannaiD· 2 shared Laura Alethia de la FuenteiD· 2 shared Federico ZamberlániD· 1 shared Lucie Janeckova· 1 shared Martin KuchařiD· 1 shared Matías Palmucci· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Carla PallaviciniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Psilocybin-induced modulation of visual salience processing

Stephanie L. Muller, Federico Cavanna, Laura Alethia de la Fuente, Nicolás Marcelo Bruno, Tomás Ariel D’Amelio, Carla Pallavicini, Enzo Tagliazucchi

This study examines how psilocybin affects visual salience processing by analyzing eye-tracking and EEG data during natural scene perception.

Neuroscience of Consciousness · Jan 1, 2025Peer-reviewedNeuroscience

Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity

Federico Cavanna, Stephanie L. Muller, Laura Alethia de la Fuente, Federico Zamberlán, Matías Palmucci, Lucie Janeckova, Martin Kuchař, Carla Pallavicini, Enzo Tagliazucchi

This study investigates the effects of microdosing psilocybin mushrooms using a double-blind placebo-controlled design and finds that active doses produce more intense subjective effects, with mixed results on other measures.

bioRxiv · Nov 30, 2021 · PreprintNeuroscience